ScopusElsevier Scopus
Status
Active
Coverage
2020–2026
Source type
Journal
Open access
Yes
CiteScore
5.4
Best quartile
Q2 · 67th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 140 / 428 | 67th | Q2 |
| Cancer Research | 115 / 233 | 50th | Q2 |
Exploration of Targeted Anti-tumor Therapy
ISSN 2692-3114
Publisher: Open Exploration Publishing Inc
Scopus · Q2Open Access
5.4
CiteScore 2025
Scopus
Q2
Best quartile
67th percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.